Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Recommendation of “Buy” by Brokerages

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, one has given a buy recommendation and four have given a strong buy recommendation to the company.

Several research analysts recently issued reports on the company. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. UBS Group upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Finally, Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th.

Check Out Our Latest Report on Reckitt Benckiser Group

Reckitt Benckiser Group Price Performance

OTCMKTS:RBGLY opened at $12.02 on Wednesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. The firm has a 50-day moving average price of $12.29 and a two-hundred day moving average price of $11.80. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $15.03.

Reckitt Benckiser Group Company Profile

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.